west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "陈玉华" 10 results
  • 主动脉夹层动脉瘤腔内隔离术后并发急性脊髓缺血损伤一例护理

    Release date: Export PDF Favorites Scan
  • 心脏瓣膜置换同期应用双极射频消融术治疗心房纤颤患者的术后护理

    摘要:目的:总结54例心脏瓣膜置换同期应用双极射频消融术治疗心房纤颤患者的术后护理经验。方法:除做好瓣膜置换术后常规护理外,重视心律和心率的监测、电解质平衡的维持、应用胺碘酮的观察及护理、起搏器的观察、抗凝监测和健康指导与心理护理。结果:通过严密的监测和精心的护理,本组病例术后恢复良好,术后7~10 d出院。结论:做好心脏瓣膜置换同期应用双极射频消融术治疗心房纤颤患者的术后护理,认真观察患者瓣膜置换、消融术后心房纤颤治疗效果,为此类患者的生命质量提高提供了保证。

    Release date:2016-08-26 03:57 Export PDF Favorites Scan
  • 冷冻球囊行肺静脉电隔离治疗阵发性心房颤动二例

    Release date: Export PDF Favorites Scan
  • 心腔内超声及超声三维建模指导下行特发性左心室室性心动过速消融一例

    Release date:2016-10-28 02:02 Export PDF Favorites Scan
  • 新型口服抗凝剂出血并发症的治疗

    近年来,新型口服抗凝剂(new oral anticoagulants,NOAC)已经逐渐成为替代华法林用于血栓栓塞性疾病的预防和治疗药物。目前经过Ⅲ期临床试验验证的 NOAC 主要包括:直接凝血酶抑制剂(达比加群)和 Xa 因子抑制剂(利伐沙班、阿哌沙班、依度沙班)。NOAC 抗凝效能比华法林强,而出血、与食品和药物相互作用的几率较低。此外,NOAC 具有更可预测的抗凝作用,剂量固定,不需常规的抗凝活性监测。自 NOAC 投入使用以来,在缺乏特异性拮抗剂逆转抗凝的情况下遭遇危及生命的出血性并发症或急诊手术已经成为临床医生关注的主要问题,该类药在有较高的出血风险的患者中使用有一定的限制。新的特异性抗体(如:Idarucizumab、Andexanetα、Ciraparantag)试验结果数据喜人,并可能很快投入临床使用。该文回顾分析了解 NOAC 的药物代谢动力学、出血性并发症的发生率及预后、逆转抗凝的方法以及特异拮抗剂的最新进展。

    Release date:2017-06-22 02:01 Export PDF Favorites Scan
  • 应用 Cool Flex 冷盐水射频消融导管行阵发性心房颤动消融一例

    Release date:2017-10-27 11:09 Export PDF Favorites Scan
  • 1例肺动脉夹层动脉瘤临床抢救护理

    我科于2009年2月11日收治1例先天性心脏病合并双侧肺动脉夹层动脉瘤患者,心界不大,心律齐,肺动脉区及主动脉区可闻及第一心音亢进,口唇发绀。经过临床抢救,通过快速使降压药物、镇痛、镇静,严密观察血压变化,将患者血压控制在100~120mmHg/60~80mmHg,同时观察用药后的不良反应,给予恰当对症处理。为患者提供舒适、安静治疗环境,以及饮食指导、心理护理等措施,患者顺利渡过危险期。

    Release date:2016-09-08 10:00 Export PDF Favorites Scan
  • 应用 Pentaray 高密度标测导管行心房纤颤消融术后房性心动过速消融一例

    Release date:2017-08-22 11:25 Export PDF Favorites Scan
  • EFFECTS OF PLATELET-RICH PLASMA ON BMSCs DIFFERENTIATION INTO SC IN VITRO

    Objective To explore effect of platelet-rich plasma (PRP) on rabbit BMSCs differentiation into SC in vitro and to detect secretory function of the differentiated cells. Methods BMSCs isolated from 5 mL bone marrow of 2-montholdNew Zealand white rabbit were cultured using density gradient centrifugation and adherence screening methods. A total of 5 mL femoral vein blood was obtained from rabbits to prepare PRP using modified Appel method. The BMSCs at passage 3 were divided into three groups: the combined induction group, in which the cells were cultured with complete medium containing PRP after β-mercaptoethanol and retinoic acid inductions; the simple induction group, in which the cells were cultured with L-DMEM complete medium without PRP afterβ-mercaptoethanol and retinoic acid induction; the control group, in which the cells were cultured with L-DMEM complete medium. Growth condition of the cells in each group was observed using inverted microscope. cell identification was conducted at 4, 7, 9, and 11 days after culture using immunofluorescence staining method, and NGF content was detected by ELISA method. NGF mRNA expression was assayed by RT-PCR 11 days after culture. Results Most cells in the combined induction and the simple induction group were out of BMSCs typical cell morphology 4 days after culture; cells in the combined induction group were out of BMSCs typical cell morphology and changed into cells resembl ing SC in terms of morphology and contour 9 days after culture. The cells in the control group showed no obvious morphological changes. S-100 protein expression in the cells was evident in the combined induction and the simple induction group at each time point after induced culture; the positive expression rate of cell in each group was increased over time, and significant differences were evident between the combined induction group and the simple induction group 7, 9, and 11 days after culture (P lt; 0.05). Control groupwas negative for the expression. There were significant differences when comparing the control group with the combined induction group or the simple induction group in terms of NGF content at each time point (P lt; 0.01). Significant difference was evident between the combined induction group and the simple induction group 7, 9, and 11 days after culture (P lt; 0.05), and no significant difference was noted 4 days after culture (P gt; 0.05). Relative intensity of NGF mRNA expression in the combined induction group was greater than that of the simple induction group 11 days after culture (P lt; 0.05). Conclusion Rabbit BMSCs can differentiate into SC excreting NGF under certain induction condition in vitro. PRP can remarkably promote BMSCs differentiation into SC.

    Release date:2016-09-01 09:07 Export PDF Favorites Scan
  • The Comparison of Efficacy and Safety of Rosiglitazone Sodium on Type 2 Diabetes with or without Non-alcoholic Fatty Liver Disease

    目的 观察罗格列酮钠对血糖控制未达标的2型糖尿病(T2DM)合并与不合并非酒精性脂肪肝(NAFL)患者的降糖疗效和安全性。 方法 2009年1月-2011年1月60例仅用磺脲类和二甲双胍治疗血糖控制未达标的T2DM患者,按合并和不合并NAFL分为观察组和对照组各30例,两组均在原口服降糖药基础上联合加用国产罗格列酮钠4 mg 1次/d,治疗共3个月,观察治疗前后的血糖、胰岛素、糖化血红蛋白(HbA1c)、体质量指数(BMI)、血脂、肝功、血压水平以及药物不良反应,并比较治疗后的血糖达标率。 结果 两组患者治疗后的空腹血糖(FPG)、餐后2 h血糖(2hPG)、HbA1c、空腹胰岛素、甘油三酯和极低密度脂蛋白胆固醇均较治疗前下降,高密度脂蛋白胆固醇较治疗前升高(P<0.05),而丙氨酸转氨酶、总胆固醇、低密度脂蛋白胆固醇及血压无明显变化(P>0.05),但观察组治疗后的FPG和2hPG均较对照组下降更明显(P<0.01),且血糖达标率为73.3%,显著高于对照组的46.7%(P<0.05),同时观察组餐后2 h胰岛素(2hINS)水平在治疗前后均明显高于对照组而且治疗后有显著下降(P<0.01),但对照组治疗后2hINS虽然也有下降但无统计学意义(P>0.05)。观察组治疗前后BMI无明显变化,但对照组治疗后BMI有明显的升高(P<0.05)。结论 国产罗格列酮钠片对血糖控制未达标的T2DM合并和不合并NAFL患者均有进一步降低血糖、HbA1c以及改善血脂的作用,但对T2DM合并NAFL的患者的降糖疗效更显著,未见加重肝功能损坏,不良反应小,可作为此类患者联合用药的一种选择。

    Release date:2016-09-08 09:14 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content